Takeda Pharmaceutical Co Ltd (TKPHF) Net Margin (2017 - 2026)
Takeda Pharmaceutical (TKPHF) posted quarterly Net Margin of 9.28% for Q2 2026, down 195.0% year-over-year from 9.77% in Q2 2025, and down 8.86% quarter-over-quarter from 10.18% in Q1 2026.
Takeda Pharmaceutical Co Ltd (TKPHF) Net Margin (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's Net Margin history runs 10 years deep, the most recent figure standing at 9.28% for Q2 2026.
- In Q2 2026, Net Margin fell 195.0% year-over-year to 9.28%; the TTM figure through Jun 2026 stood at 1.24% (down 399.0% YoY), while the FY2026 annual figure was 3.38%, down 574.0% from the prior year.
- Net Margin for Q2 2026 stood at 9.28%, down from 10.18% in the prior quarter.
- The five-year high for Net Margin was 11.23% in Q2 2025, with the low at 33.67% in Q4 2025.
- The 5-year median for Net Margin is 8.16% (2023), against an average of 4.57%.
- The sharpest annual moves came in 2022 and 2023: Net Margin tumbled 2676 bps in 2022, then soared 1109 bps in 2023.
- Takeda Pharmaceutical's Net Margin stood at 10.86% in 2022, then plunged by 73 bps to 2.96% in 2023, then slumped by 431 bps to 9.8% in 2024, then plunged by 244 bps to 33.67% in 2025, then soared by 128 bps to 9.28% in 2026.
- Business Quant data shows TKPHF's Net Margin at 9.28% in Q2 2026, 10.18% in Q1 2026, and 33.67% in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.28% |
| Mar 31, 2026 | 10.18% |
| Dec 31, 2025 | -33.67% |
| Sep 30, 2025 | 6.12% |
| Jun 30, 2025 | 11.23% |
| Mar 31, 2025 | 10.28% |
| Dec 31, 2024 | -9.80% |
| Sep 30, 2024 | 5.98% |
| Jun 30, 2024 | 7.88% |
| Mar 31, 2024 | 7.88% |
| Dec 31, 2023 | 2.96% |
| Sep 30, 2023 | 8.90% |
| Jun 30, 2023 | 8.44% |
| Mar 31, 2023 | 9.92% |
| Dec 31, 2022 | 10.86% |
| Sep 30, 2022 | 6.16% |
| Jun 30, 2022 | 10.80% |
| Mar 31, 2022 | -1.17% |
| Dec 31, 2021 | 6.41% |
| Sep 30, 2021 | 5.44% |